Publication dates

Cancer Vaccine Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Therapeutics, Drug, more »


 
1-10 of about 100 reports for Cancer Vaccine

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • Dec 2014
  • by BCC Research

... Countries such as india, china, japan, korea, taiwan, canada, africa, australia and new zealand. The application of cancer vaccines in various types of cancer is discussed from both commercial perspective ...

Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

... Also includes numerous tables and figures that illustrate the trends and activities in cancer vaccine partnering and dealmaking since 2009. ...

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Medical's imenvax device delivers immune catalysts which activates the patient's immune cell. The company's areas of operations include immuno-therapeutic cancer vaccine for canines, veterinary clinics ...

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Designed to train the immune system to recognize and attack cancer cells and dpx-survivac is a clinical-stage cancer vaccine. Imv's depovax platfrom is a patented vaccine delivery formulation that provides ...

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And a multivalent cancer vaccine targeting two epitopes of her-2, vald tumor associated antigens. The company principally focuses on the development of personalized cancer treatment with the selection ...

KAEL-GemVax Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

KAEL-GemVax Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Affitech completes sale of its remaining rights of cancer vaccine to gemvax 10gemvax & kael completes acquisition of remaining stake in kael-gemvax for us$9.7 Million 11kael acquires gemvax 12 ...

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Offering of us$18 million 33expres2ion biotech acquires ip rights related to recombinant protein production technology from affitech 35affitech completes sale of its remaining rights of cancer ...

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... And treatment of cancer and viral infections for the research and design of anti-viral and anti cancer vaccines. Altor is headquartered in miramar, florida, the us.Altor bioscience corporation ...

Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adamis Pharmaceuticals Corporation (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Deals summary, 2008 to ytd 2014 10adamis pharma acquires cancer vaccine technology from the regents of the university of california 11adamis enters into co-development agreement with beximco 12 ...

Product and Pipeline Analysis of the Global Vaccines MarketĀ : Expected Launches in the Areas of Cancer and Allergies Will Drive Growth

Product and Pipeline Analysis of the Global Vaccines MarketĀ : Expected Launches in the Areas of Cancer and Allergies Will Drive Growth

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

... Dashboardcancer vaccine product dashboardallergy vaccine product dashboardother vaccine product dashboardtimeline of key eventsconclusions new market opportunitiesthe frost ...

About 500 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.